000 01345 a2200361 4500
005 20250515230016.0
264 0 _c20110218
008 201102s 0 0 eng d
022 _a1755-5922
024 7 _a10.1111/j.1755-5922.2010.00182.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScarpioni, Roberto
245 0 0 _aDyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
_h[electronic resource]
260 _bCardiovascular therapeutics
_cDec 2010
300 _a361-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCardiovascular Diseases
_xetiology
650 0 4 _aChronic Disease
650 0 4 _aDyslipidemias
_xcomplications
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aKidney Diseases
_xcomplications
650 0 4 _aRenal Dialysis
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
650 0 4 _aTreatment Outcome
700 1 _aRicardi, Marco
700 1 _aMelfa, Luigi
700 1 _aCristinelli, Luciano
773 0 _tCardiovascular therapeutics
_gvol. 28
_gno. 6
_gp. 361-8
856 4 0 _uhttps://doi.org/10.1111/j.1755-5922.2010.00182.x
_zAvailable from publisher's website
999 _c19902456
_d19902456